These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25445526)

  • 1. High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: application to intravitreal ocular administration.
    Sarkhel S; Ramsay E; Kontturi LS; Peltoniemi J; Urtti A
    Int J Pharm; 2014 Dec; 477(1-2):469-75. PubMed ID: 25445526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate microspheres obtained by the spray drying technique as mucoadhesive carriers of ranitidine.
    Szekalska M; Amelian A; Winnicka K
    Acta Pharm; 2015 Mar; 65(1):15-27. PubMed ID: 25781701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical challenges for developing long acting intravitreal medicines.
    Awwad S; Henein C; Ibeanu N; Khaw PT; Brocchini S
    Eur J Pharm Biopharm; 2020 Aug; 153():130-149. PubMed ID: 32445965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology.
    Andrés-Guerrero V; Zong M; Ramsay E; Rojas B; Sarkhel S; Gallego B; de Hoz R; Ramírez AI; Salazar JJ; Triviño A; Ramírez JM; Del Amo EM; Cameron N; de-Las-Heras B; Urtti A; Mihov G; Dias A; Herrero-Vanrell R
    J Control Release; 2015 Aug; 211():105-17. PubMed ID: 26003040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the posterior segment of the eye IV: theoretical formulation of a drug delivery system for subconjunctival injection.
    Lee TW; Robinson JR
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):29-37. PubMed ID: 19232010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems.
    Wu Z; Hassan D; Shaw JP
    J Pharm Pharmacol; 2013 Oct; 65(10):1429-39. PubMed ID: 24028610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA; Castro GR
    Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.
    Jain D; Bar-Shalom D
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1576-84. PubMed ID: 25109399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsponges: A Pioneering Tool for Biomedical Applications.
    Kumari A; Jain A; Hurkat P; Verma A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):77-105. PubMed ID: 27279339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.